Member Info for rogerDSH

Does 'Lo I am both' really believe that any readers other than total cowboy punters will be influenced by his simplistic/disingenuous/multitudinous/ exhausting ramblings ?

Does 'Lo I am both' really believe any readers other than total cowboy punters will be influenced by his simplstic/disingenuous/multititudinous/ exhausting ramblings ?

Re: Lo...I am both ( and possibly more )
He's working very hard...full day shift perhaps...who do we think is paying him ?

Liam Booth...Lo I am both
Coincidece ?

If I remember correctly, the regulator specified the use of Demasys as placebo, having said that ....not a simple substance, so a bit of investigation to eliminate any potential problem, would not have come amiss.

I don't doubt that parties putting money in have personally tried it...why wouldn't they ? Bearing this in mind...massive vote of confidence.
FDA requirements are likely to be
Considerably relaxed, due to data available from previous trial.
Simon Thompson of IC may well be commenting favourably in next issue.

As ndr has stated FUTURA 75 is the name give to one of many hemp strains....see Wiki listing.
Does not appear to me to have any connection to Futura Medical

Matm did not say Synairge has a wide range of vaccines....he said 'we' ....referring to world in general ....he referred to SNG as a treatment

Let's remind ourselves
..the current market cap...ONLY £329m.
What is the value of a company which arguably holds the answer to what is arguably the biggest problem faced by every country in the world

Is 1million a 'bargain' or is it a ludicrously low valuation ?
Would someone wih more knowledge than myself of company market valuations particularly pharmaceutical take a view, based on realistic estimates of likely market size, sales, profit, EPR etc ?

Just testing whether posting board down

RNS7182X 20.12.19
ADDITIONAL INFORMATION
'Dermasys is a proprietary patented drug delivery technology platform.
------------------------------------------------------------------------------
It is a clear odourless gel that provides rapid and targeted local delivery to the required site of action.'
This is clearly reference to carrier only not medicated gel

Assuming the way ahead becomes clear in the not too distant future, then bearing in mind size of market, selling price v cost of production, surely '50p by Christmas' is a huge underestimate

In case not been noticed....content of rns, essence of recent trial result and share surge reported today .

ST comments today on 2019 portfolio. Re FUM....mainly narrative but 'maintaining a watching brief for now ahead of future newsflow'

MED was not/ is not flawed; Dermasys was not/is not flawed. What was flawed beyond belief was the trial protocol...effectively there was NO placebo.

The trial regulators inexplicably specified Dermasys with knowledge of ilts design purpose ...knowing it had a mechanical action.

FUM, beggaring belief accepted, well aware that the 'placebo' was a substance penetrating to the vascular level ...which should have given pause for thought and a half day's work with some simple tests.
Surely anyone with intelligence/commonsense should have been wary.
I would have thought-probably wrongly, that in the circumstances, the regulatory authorities would be keen to 'oil the wheels' to enable further progress
I

Lord Topup
Mr Adams: refer to Jonah's post of Wednesday and previous posts re Mr Adam's
identity

See Jonah's post...Wed 10.17.
Source of this info mentioned in a post some weeks back.

.......and if he rates it a sell at these prices, bearing in mind his wide readership and fairly impressive record....then surely quite an adverse effect

I would not be expecting ST to comment in any detail on the technical aspects or endorse the product but my thought is that in surveying the situation, the tone of his aricle (assuming there is one), might well influence (one way or the other ) sh level of confidence in bod and their handling of the situation.